Enochian Biosciences Said On June 20 It Entered Into Purchase Agreement With Lincoln Park Capital Under Which It May Sell To Lincoln Park Up To $20M Of Shares Of Common Stock
Portfolio Pulse from Charles Gross
Enochian Biosciences (ENOB) entered into a purchase agreement with Lincoln Park Capital, allowing it to sell up to $20 million of common stock to Lincoln Park.
June 27, 2023 | 10:08 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Enochian Biosciences (ENOB) signed a purchase agreement with Lincoln Park Capital, potentially raising up to $20 million through the sale of common stock.
The purchase agreement with Lincoln Park Capital allows Enochian Biosciences to raise up to $20 million through the sale of common stock. This additional capital could be used to fund the company's operations, research, and development, potentially leading to positive outcomes for the company and its investors. As a result, the stock price is likely to go up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100